Corpusense

Henry Schein (HSIC) earnings call transcript summary & sentiment

Last call Tue 4 Aug 2026·Next expected Tue 3 Nov 2026not yet confirmed

Our read on the 4 August 2026 earnings call

Overall tone: Positive

Overall tone

Positive

Executive Summary

Henry Schein delivered solid quarterly financial results featuring internal local currency sales growth of 4.6% and non-GAAP EPS growth of 15.5% to $1.27.

Core Signals

Revenue Growth & Demand: Global sales reached $3.5 billion with internal local currency sales growth of 4.6%, led by 6.5% internal growth in U.S. dental merchandise.

Bullish Signals

U.S. dental merchandise internal local currency sales growth reached 6.5%, significantly pacing above broader market growth rates.

Risk Signals

U.S. dental equipment sales fell 1.1% in the quarter due to tough prior-year comparisons involving large institutional dental school orders.

Q&A Signals

Repeated analyst topics: Analysts repeatedly questioned how value creation cost savings will flow into second-half EBIT and requested details on gross margin expansion components.

Key Investor Debate

The primary debate among investors centers on whether Henry Schein can deliver expected second-half operating leverage without relying on prior-year remeasurement gains.

Analyst Takeaway

Management's narrative is backed by operational execution across core distribution and high-margin technology/specialty platforms, which now represent nearly 50% of operating income.

Those are the opening lines. The full read covers the whole earnings transcript: every bullish and bearish signal, what analysts pressed hardest on, and where management answered vaguely — each with the quote behind it. Every line sourced.

See the full Earnings Highlight

Themes across Henry Schein and the Health Care sector

Analyse a theme over quarters — what's brand new, what's being talked about more, and what is spreading to more companies across the sector.

Unlock themes

Ask about Henry Schein's earnings, or other S&P 500 earnings calls

Ask across the corpus, instead of reading one call at a time. Scope it to Henry Schein, its sector, or every name we cover — plain English, no operators — and answers come back structured: a summary, the drivers, and a read on each company.

"What did Henry Schein say about margins, and did the framing change from last quarter?"

"Did Henry Schein's management walk back any full-year guidance, and how did they frame it?"

"Where did Henry Schein avoid answering on capital allocation?"

Unlock search

Earnings call history & sentiment

6 of its last 7 calls fell on a Tuesday, every one at 08:00 ET, before the open.

Date Day Period Corpusense read
2026-08-04Tuesday2026 Q3Positive
2026-05-05Tuesday2026 Q2Positive
2026-02-24Tuesday2026 Q1Positive
2025-11-04Tuesday2025 Q4—
2025-08-05Tuesday2025 Q3—
2025-05-05Monday2025 Q2—
2025-02-25Tuesday2025 Q1—

Earnings calls across Health Care Providers & Services

The companies Henry Schein is read alongside. Each has its own earnings call dates and sentiment.

CAHCardinal HealthCICignaCNCCentene CorporationCORCencoraCVSCVS HealthDGXQuest DiagnosticsDVADaVitaELVElevance Health

Henry Schein is one of the S&P 500 companies we track

Sentiment analysis on any single earnings call, themes building across a sector, and search across every company and quarter — each claim linked back to the passage it came from.

Create a free account See the full calendar Plans & pricing